Year archive

Akeso, Inc. — 2026 filings

All 11 regulatory filings released by Akeso, Inc. (9926) in 2026, sourced directly from the official regulator.

11 Filings

2026 Period

2026 filings (11)

Filing	Released	Lang
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 April 2026 Regulatory Filings	2026-05-06	English
Notification Letter and Reply Form to Non-registered Holders - Reminder letter regarding the Arrangement of Electronic Dissemination of Corporate Communications Regulatory Filings	2026-04-29	English
Notification Letter and Reply Form to Registered Shareholders - Reminder letter regarding the Arrangement of Electronic Dissemination of Corporate Communications Regulatory Filings	2026-04-29	English
2025 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT Regulatory Filings	2026-04-29	English
2025 ANNUAL REPORT Regulatory Filings	2026-04-29	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025 Earnings Release FY 2025	2026-03-26	English
DATE OF BOARD MEETING Report Publication Announcement	2026-03-16	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 January 2026 Share Issue/Capital Change	2026-02-05	English
VOLUNTARY ANNOUNCEMENT - AKESO GRANTED EXCLUSIVE COMMERCIALIZATION RIGHTS FOR EBRONUCIMAB INJECTION TO JUMPCAN PHARMACEUTICAL Regulatory Filings	2026-02-03	English
CONTINUING CONNECTED TRANSACTION FURTHER INFORMATION IN RELATION TO THE CONTRACT MANUFACTURING ARRANGEMENT Regulatory Filings	2026-01-26	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 December 2025 Share Issue/Capital Change	2026-01-06	English